Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the global burden of disease study 2023

Simple item page
dc.contributor.authorOkonji, Osaretin Christabel
dc.contributor.authorLedesma, Jorge R
dc.contributor.authorZhang, Meixin
dc.contributor.authorLiew, Mei Fong
dc.contributor.authorDominguez, Regina-Mae Villanueva
dc.date.accessioned2026-08-12T08:46:59Z
dc.date.available2026-08-12T08:46:59Z
dc.date.issued2026
dc.description.abstractTuberculosis (TB) is the leading global cause of death from a single infectious agent. Recent reductions in global health funding have threatened TB control, making comprehensive assessment of TB, HIV-related TB, and drug-resistant TB burdens before these disruptions essential for shaping effective responses. The WHO End TB Strategy sets targets of a 95% reduction in TB deaths and a 90% reduction in TB incidence between 2015 and 2035. Using results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023, this study aims to assess the burden of TB and multidrug-resistant TB (MDR-TB) across 204 countries and territories, and to evaluate progress towards the WHO End TB incidence and mortality targets.
dc.identifier.citationLedesma, J.R., Zhang, M., Liew, M.F., Dominguez, R.M.V., Whikehart, S.M.L., Verma, M., Ma, J., Movo, A., Chu, H.T., Ostroff, S.M. and He, J., 2026. Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet infectious diseases.
dc.identifier.urihttps://doi.org/10.1016/S1473-3099(26)00295-1
dc.identifier.urihttps://hdl.handle.net/10566/25131
dc.language.isoen
dc.publisherElsevier Ltd
dc.subjectTuberculosis (TB)
dc.subjectMultidrug-resistant tuberculosis (MDR-TB)
dc.subjectHIV
dc.subjectHIV-associated tuberculosis
dc.subjectGlobal Burden of Disease (GBD)
dc.titleGlobal, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the global burden of disease study 2023
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
okonji_global_regional_and_national_2026pdf
Size:
19.87 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (School of Pharmacy)